After years battling Silicon Valley skeptics and Wall Street adversaries, Michael Dell has pulled off the deal of the century, borrowing and flipping his way to a $50 billion fortune...
When Sardar Biglari, CEO of Biglari Holdings, won a hotly contested shareholder proxy in April, investors feared his next move would be to cement control over the company. They were right, and a review of Biglari’s actions in recent months shows he did so with the help of leading Wall Street investment banks...
Citrix Systems , best known for its online GoToMeeting service may be preparing for a series of meetings of its own. Jesse Cohn, a technology-focused portfolio manager with powerful activist hedge fund Elliott Management, disclosed a 7.1% stake in Citrix and a plan to work with the company on improving its operations, while also selling or spinning corporate assets...
Tempur Sealy International on Monday unveiled a settlement with hedge fund H Partners that will revamp the mattress company's board of directors and lead to change atop the Lexington, Ky-based company...
Hedge fund H Partners scored a victory on Friday in its bid to unseat directors from the board of mattress giant Tempur Sealy International, indicating widespread investor dissatisfaction with the company's financial results and management...
Just weeks after failing to win regulatory support for a $45 billion takeover of competitor Time Warner Cable, Comcast reported a strong rise in profits and an significant increase in its quarterly dividend and annual share repurchase authorization...
Nelson Peltz's Trian Management sees governance issues at Chemours as all the more reason to continue fighting its proxy war against DuPont...
There's little reason left to support self-dealing CEO Sardar Biglari or the company's inattentive board of directors, but an activist slate run by fledgling hedge fund Groveland Capital poses a murky path forward...
In one fell swoop, chemical and materials titan DuPont may have diffused an aggressive campaign run by hedge fund Trian Management and also impressed its shareholders...
Zoetis, an animal health company spun off from Pfizer in 2013, is taking a representative from Bill Ackman's hedge fund Pershing Square Capital Management onto its board of directors...
Family Dollar has now set a vote on the merger for Jan. 22, potentially giving CEO Howard Levine the ability to close one of the most hotly contested merger efforts in recent memory, which has drawn in backlash from consumer groups and a handful of powerful Wall Street investors...
Even Bank of America's critics are likely to mostly agree with Buffett's positive reviews of CEO Brian Moynihan...
